Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib in HER2+ MBC.
|Videos|March 18, 2019
Oncology Nurses Are a 'Lifeline for Management' in Cancer Care
Author(s)Hope S. Rugo, MD
Oncology nurses are crucial in the management of cancer symptoms and treatment-related adverse events.
Advertisement
Oncology nurses are crucial in the management of cancer symptoms and treatment-related adverse events, explained Hope S. Rugo, the director of Breast Oncology and Clinical Trials Education at the University of California San Francisco Comprehensive Cancer Center.
Nurses work hand-in-hand with doctors, and by staying in touch with patients, they offer them a "lifeline for management," Rugo said, citing that a recent study even found that the upfront management of symptoms can lead to better outcomes.
Advertisement
Related to this article
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Two Winship nurses explain how to talk with breast cancer survivors about GLP-1 receptor agonists, from endocrine therapy to access barriers.
For MBC Awareness Day, an NP and a former ICU nurse living with metastatic breast cancer discuss repeat education, biomarker testing, and support.
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
Marieta Branis, APN, discusses individualized breast cancer care, monitoring for ADC and oral therapy toxicities, younger patients, and survivorship.
Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Accelerated Approval to Dostarlimab in dMMR Rectal Cancer
2
Anktiva Plus BCG: 84% of Responders Cystectomy-Free at 3 Years
3
Tucatinib Maintenance for HER2+ Breast Cancer: What Nurses, PAs Should Know
4
How AI Could Ease the Cost Crisis in Cancer Care
5